MDS Pharma Services

MDS Pharma Services, established in 1966, is a prominent entity within the Business Services sector, specializing in comprehensive drug discovery and development solutions. The company caters to the global pharmaceutical and biotechnology industries, focusing on enhancing the efficiency and effectiveness of bringing new therapies to market. Its core mission revolves around providing integrated services that span the entire drug development lifecycle, from initial discovery phases through to preclinical and clinical research.

The organization offers a broad spectrum of services, including drug safety assessment and regulatory affairs support, leveraging a dedicated team of internationally respected scientists. This expertise is crucial for delivering high-quality results that positively impact clients' drug development programs. With a global footprint, MDS Pharma Services operates across 13 locations worldwide, ensuring strategic positioning to meet diverse client needs. The company employs between 1,000 and 5,000 professionals, forming a robust operational structure. Meet MDS Pharma Services's team to understand the caliber of professionals driving these advancements.

MDS Pharma Services generates an annual revenue of $198.5M. Its product and service portfolio encompasses critical areas such as life science research, drug discovery, preclinical and clinical studies, safety evaluation, and data management. The company operates within a competitive landscape, facing rivals like Certara, Sotera Health, and Sterigenics, all vying for market share in the complex pharmaceutical services domain. Through its specialized offerings and strategic global presence, MDS Pharma Services aims to be a key partner in advancing pharmaceutical innovation.